Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

Lagos to Mombasa

Lagos to Mombasa: How Does the Pandemic End in Africa?

This first episode of the new Africa-centered podcast series Lagos to Mombasa examines how African governments can shape their responses to the pandemic and prepare for the future. Patrick Tippoo of Biovac and the African Vaccine Manufacturing Initiative and Prashant Yadav from CGD join Gyude Moore to discuss options and opportunities.

A gloved hand holds a COVID-19 vaccine vial in front of a blue background

Dear President Biden and Congress: Time for US to Lead Response to the Growing COVID-19 Global Vaccine Crisis

Today we joined colleagues from CSIS, Duke University, and the COVID Collective in an open letter to the Biden Administration and US Congress with a clear message: to hasten the end of the COVID-19 global pandemic, American leadership is required to ensure universal global access to high-quality and safe vaccines, support rapid vaccine distribution and administration, and build a sustainable global network of vaccine manufacturing capacity. Vaccines offer an exit route out of the pandemic – but only if they reach a critical mass of people in need across continents, socioeconomic strata, and marginalized populations.

A close up of medical supplies, including syringes, at a hospital in Sri Lanka

Expanding Health Product Manufacturing in Africa: Ideas for Development Finance Institutions, Procurers, and Policymakers

In October 2020, the Center for Global Development—in partnership with African Union Development Agency-NEPAD (AUDA-NEPAD), UN Economic Commission for Africa (UNECA), and the African Leaders Malaria Alliance—hosted a high-level roundtable on regional health product manufacturing in Africa. This blog is based on the authors’ reflections of the roundtable.

Young women work at a pharmaceutical company in Afghanistan

COVID-19 Surfaces New Directions for Old Challenges: Three Lasting Ways to Improve Global Health Procurement

Effective and efficient procurement of health products—medicines, diagnostics, and devices—is a critical function of all strong health systems. The pandemic has exacerbated long-standing challenges—as highlighted by a recent CGD Working Group—in the purchasing of both COVID-related emergency supplies and other essential health products.

Pages